Detalhe da pesquisa
1.
Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.
N Engl J Med
; 390(9): 819-829, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416430
2.
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
Oncologist
; 28(9): 799-803, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226534
3.
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
Support Care Cancer
; 31(5): 256, 2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043087
4.
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
JAMA
; 327(20): 1963-1973, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608580
5.
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Pharmacogenet Genomics
; 31(1): 1-9, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649577
6.
A descriptive cost-analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high-dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
Eur J Haematol
; 107(3): 333-342, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34053112
7.
Who will receive the last ventilator: why COVID-19 policies should not prioritise healthcare workers.
J Med Ethics
; 47(9): 599-602, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172525
8.
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.
Cancer
; 126(22): 4859-4866, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910476
9.
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.
Breast Cancer Res
; 21(1): 47, 2019 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944027
10.
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer.
Pharmacogenet Genomics
; 29(8): 183-191, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31211741
11.
Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation?
Transfusion
; 59(7): 2308-2315, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31059586
12.
Erosion of informed consent in U.S. research.
Bioethics
; 33(1): 4-12, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30474129
13.
Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery: The FIBRES Randomized Clinical Trial.
JAMA
; 322(20): 1966-1976, 2019 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31634905
14.
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Breast Cancer Res Treat
; 169(3): 537-548, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29455298
15.
TCL1A, a Novel Transcription Factor and a Coregulator of Nuclear Factor κB p65: Single Nucleotide Polymorphism and Estrogen Dependence.
J Pharmacol Exp Ther
; 365(3): 700-710, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29592948
16.
A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.
Haematologica
; 103(2): 288-296, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29097500
17.
Is There a Doctor in the House?
Am J Bioeth
; 23(8): 47-50, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450521
18.
TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response.
Mol Pharmacol
; 92(2): 175-184, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28615284
19.
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
Cancer
; 123(13): 2444-2451, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464211
20.
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Breast Cancer Res Treat
; 164(3): 571-580, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28484925